HLH Imaging Group promises clear and consistent reporting in prostate MRI

Provider of lung cancer screening in England, The HLH Imaging Group has used its nationally-integrated NHS architecture, AI-supported approach and collaboration with leading figures in prostate imaging to add a prostate MRI reporting arm that now provides services to several NHS and independent institutions.

Using the DeepHealth Prostate AI platform, HLH Prostate provides NHS trusts with quality prostate teleradiology reporting, benchmarked against national standards. The company says providing clear recommendations to direct further management, including biopsy, is at the heart of its strategy. Clear and consistent template-based reporting is standard, including PI-RADS scoring and AI-generated contouring of suspicious lesions, with additional pictorial-based reports assisting biopsy planning.

Automated prostate segmentation provides accurate prostate volume and prostate-specific antigen density measurements. “HLH Prostate is operated by consultant uroradiology opinion leaders with knowledge of current prostate cancer pathways,” the company says. “Reporting is data driven, with extensive QA and audit, ensuring genuine subspecialist reporting. Adhering to the stringent UK prostate cancer national pathway targets is a priority for all trusts and, as such, the 72-hour turnaround is a crucial KPI, helping to avoid bottlenecks in the pathway.”

Pictures: DeepHealth Prostate software uses AI to streamline workflow.

Read this report on page 8 of the January 2026 issue of RAD Magazine.